Literature DB >> 32436584

Atrial flow regulator as a novel therapy for patients with chronic heart failure.

Łukasz Lewicki1,2, Robert Sabiniewicz3, Janusz Siebert4,5, Marek Szołkiewicz6.   

Abstract

Entities:  

Keywords:  atrial flow regulator; heart failure; interatrial shunting

Mesh：

Year:  2020        PMID： 32436584      PMCID： PMC8015977          DOI： 10.5603/CJ.a2020.0077

Source DB:  PubMed          Journal:  Cardiol J        ISSN： 1898-018X            Impact factor:   2.737


× No keyword cloud information.
  9 in total

1.  The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction.

Authors:  Christina Paitazoglou; Ramazan Özdemir; Roman Pfister; Martin W Bergmann; Jozef Bartunek; Teoman Kilic; Alexander Lauten; Alexander Schmeisser; Mehdi Zoghi; Stefan Anker; Horst Sievert; Felix Mahfoud
Journal:  EuroIntervention       Date:  2019-08-29       Impact factor: 6.534

2.  Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure.

Authors:  Jay Ritzema; Richard Troughton; Iain Melton; Ian Crozier; Robert Doughty; Henry Krum; Anthony Walton; Philip Adamson; Saibal Kar; Prediman K Shah; Mark Richards; Neal L Eigler; James S Whiting; Garrie J Haas; J Thomas Heywood; Christopher M Frampton; William T Abraham
Journal:  Circulation       Date:  2010-02-22       Impact factor: 29.690

3.  Atrial flow regulator for severe drug resistant pulmonary arterial hypertension after congenital heart defect correction.

Authors:  Alicja Dąbrowska-Kugacka; Dariusz Ciećwierz; Grzegorz Żuk; Marcin Fijałkowski; Antoni Ottowicz; Joanna Kwiatkowska; Ewa Lewicka; Robert Sabiniewicz
Journal:  Cardiol J       Date:  2019       Impact factor: 2.737

4.  Atrial flow regulator as a bridge to lung transplant in a young patient with drug-resistant idiopathic pulmonary arterial hypertension.

Authors:  Magdalena Janus; Sylwia Sławek-Szmyt; Aleksander Araszkiewicz; Tatiana Mularek-Kubzdela; Maciej Lesiak; Marek Grygier
Journal:  Kardiol Pol       Date:  2020-02-05       Impact factor: 3.108

Review 5.  Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.

Authors:  Barry A Borlaug; Walter J Paulus
Journal:  Eur Heart J       Date:  2010-12-07       Impact factor: 29.983

6.  Masked left ventricular restriction in elderly patients with atrial septal defects: a contraindication for closure?

Authors:  P Ewert; F Berger; N Nagdyman; O Kretschmar; S Dittrich; H Abdul-Khaliq; P Lange
Journal:  Catheter Cardiovasc Interv       Date:  2001-02       Impact factor: 2.692

Review 7.  Heart failure with preserved ejection fraction: from mechanisms to therapies.

Authors:  Carolyn S P Lam; Adriaan A Voors; Rudolf A de Boer; Scott D Solomon; Dirk J van Veldhuisen
Journal:  Eur Heart J       Date:  2018-08-07       Impact factor: 29.983

8.  One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial.

Authors:  Sanjiv J Shah; Ted Feldman; Mark J Ricciardi; Rami Kahwash; Scott Lilly; Sheldon Litwin; Chris D Nielsen; Pim van der Harst; Elke Hoendermis; Martin Penicka; Jozef Bartunek; Peter S Fail; David M Kaye; Anthony Walton; Mark C Petrie; Niki Walker; Anupam Basuray; Steven Yakubov; Scott L Hummel; Stanley Chetcuti; Rhondalyn Forde-McLean; Howard C Herrmann; Daniel Burkhoff; Joseph M Massaro; John G F Cleland; Laura Mauri
Journal:  JAMA Cardiol       Date:  2018-10-01       Impact factor: 14.676

9.  Fenestrated occluders for treatment of ASD in elderly patients with pulmonary hypertension and/or right heart failure.

Authors:  Leonhard Bruch; Anne Winkelmann; Steffen Sonntag; Franziska Scherf; Sascha Rux; Marc O Grad; Franz X Kleber
Journal:  J Interv Cardiol       Date:  2007-12-11       Impact factor: 2.279
  9 in total
  2 in total

1.  First-in-human radiofrequency ablation of ventricular tachycardia performed through an Atrial Flow Regulator device.

Authors:  Mateusz Wilkowski; Łukasz Lewicki; Rafał Olszewski; Adam Priebe; Miłosz J Jaguszewski; Marek Szołkiewicz
Journal:  Cardiol J       Date:  2020-12-21       Impact factor: 2.737

2.  Pomeranian atRial flOw reguLatOr iN conGestive hEart failuRe (PROLONGER): Study protocol.

Authors:  Łukasz Lewicki; Katarzyna Kosmalska; Sebastian Liedtke; Maciej Karwowski; Janusz Siebert; Robert Sabiniewicz; Jakub Kiedrzyn; Adrian Kot; Marek Szołkiewicz
Journal:  Cardiol J       Date:  2020-11-03       Impact factor: 2.737
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.